J
Juan Carreno
Researcher at University of Los Andes
Publications - 19
Citations - 552
Juan Carreno is an academic researcher from University of Los Andes. The author has contributed to research in topics: Kidney & Kidney disease. The author has an hindex of 10, co-authored 16 publications receiving 499 citations. Previous affiliations of Juan Carreno include Pontifical Catholic University of Chile.
Papers
More filters
Journal ArticleDOI
Urinary Exosomes as a Source of Kidney Dysfunction Biomarker in Renal Transplantation
S. Alvarez,Cristian Suazo,A. Boltansky,M. Ursu,D. Carvajal,G. Innocenti,A. Vukusich,M. Hurtado,Sandra Villanueva,Juan Carreno,A. Rogelio,Carlos E. Irarrazabal +11 more
TL;DR: Considering the highest abundance of NGAL in the urinary exosomes and its correlation with DGF patients, the exosomal fraction is suggested as a more sensitive substrate to evaluate early biomarkers of DGF after KT.
Journal ArticleDOI
Cardiac Hypertrophy: Molecular and Cellular Events
TL;DR: The purpose of this review was to provide a schematic overview of current knowledge about the molecular pathogenesis of cardiomyocyte hypertrophy, with special emphasis on new research topics and investigations.
Journal ArticleDOI
Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model.
Sandra Villanueva,Ernesto Ewertz,Flavio Carrión,Andrés Tapia,César Vergara,Carlos Cespedes,Pablo J. Sáez,Patricia Luz,Carlos E. Irarrazabal,Juan Carreno,Fernando E Figueroa,Carlos P. Vio +11 more
TL;DR: The effect of MSC (mesenchymal stem cells) on the progression of CKD and the expression of molecular biomarkers associated with regenerative effects was significantly related to the increase in renal function.
Journal ArticleDOI
Hipertrofia cardiaca: eventos moleculares y celulares
TL;DR: El objetivo ofrece mostrar esquematicamente el conocimiento actual de la patogenia molecular de the hipertrofia patologica del cardiomiocito, con enfasis en los nuevos interrogantes y lineas of investigacion.
Journal ArticleDOI
Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure
Sandra Villanueva,Juan Carreno,Lorena Salazar,César Vergara,Rocío Strodthoff,Francisca Fajre,Carlos Cespedes,Pablo J. Sáez,Carlos E. Irarrazabal,Jorge Bartolucci,Fernando E Figueroa,Carlos P. Vio +11 more
TL;DR: Evidence is provided that AD-MSCs, a less invasive and highly available source of MSCs, exert an important therapeutic effect in this pathology, and is linked to the improvement in renal function.